Duquesne
INSM · Medicine & biotech

Insmed

Makes medicines for serious lung diseases.
Bought more
Duquesne owns 1.4 million shares of Insmed, worth about $152 million. That’s $3 of every $100 they have in stocks — their 4th-biggest bet. Between April and June they bought 270,600 more (up 23%).
Mar 31
1,154,090
Jun 30
1,424,690

The numbers

Shares they own
1,424,690
Change since Mar 31
+270,600
+23.4%
Shares on Mar 31
1,154,090
Value on Jun 30, 2026
$151,900,000
about $152 million
Share of their money
3.5%
$3 of every $100 · 4th of 85
Price per share on Jun 30
$106.62
Cost of the shares they added
about $29 million
at the Jun 30 price
Kind
Shares
Also owned by
No other fund we follow
They also hold Insmed as call options.
More about Insmed
The value uses the price on Jun 30, 2026. The fund may have paid a different price.
Not investment advice. Holdings come from public SEC reports and the funds’ own letters, and can be up to 4½ months old. How this works